MP-371

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMP-371
Drug Alias Nametyrosine kinase inhibitor (Montigen)MP-371
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitorsTyrosine-protein kinase receptor RET inhibitorsTyrosine-protein kinase SRC inhibitors
TargetsStem cell growth factor receptorTyrosine-protein kinase SRCTyrosine-protein kinase receptor RET
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMontigen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMontigen Pharmaceuticals IncAstex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A